Axon Therapy
K210021 is the FDA 510(k) clearance record for Axon Therapy, a class II device, cleared for Neuralace Medical, Inc. on under FDA product code QPL (Electromagnetic Stimulator, Pain Relief). FDA's definition for product code QPL reads: "Intended to apply a magnetic-field induced electrical current to treat pain". FDA records list 2 510(k) clearances for Neuralace Medical, Inc., from to . As of , FDA records show no recalls naming K210021.
Clearance record
- Decision date
- Received
- (158 days to decision)
- Product code
- QPL Electromagnetic Stimulator, Pain Relief
- Regulation
- 21 CFR 882.5890
- Device class
- Class II
- Review panel
- Neurology
- Applicant
- Neuralace Medical, Inc. 3770 Tansy St. #101, San Diego CA
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code QPL
Trailing 12 monthsFDA records hold no clearances under product code QPL in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
